Comparative efficacy and safety of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: a systematic review and network meta-analysis

Peer Review reports

Original Submission
18 Jan 2019	Submitted	Original manuscript
4 Feb 2019	Reviewed	Reviewer Report - Franco Maggiolo
10 Feb 2019	Reviewed	Reviewer Report - Stefano Rusconi
13 Feb 2019	Reviewed	Reviewer Report - Maddalena Cerrone
15 Mar 2019	Author responded	Author comments - Sonya J. Snedecor
Resubmission - Version 2
15 Mar 2019	Submitted	Manuscript version 2
Publishing
11 Apr 2019	Editorially accepted
30 May 2019	Article published	10.1186/s12879-019-3975-6

Back to article page